Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
Not Applicable
Not yet recruiting
- Conditions
- Non-muscle-invasive Bladder Cancer
- Interventions
- Drug: Standard infusion chemotherapyProcedure: BL - 5 ala PDT
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2022-09-21
- Target Recruit Count
- 140
- Registration Number
- NCT05547516
- Locations
- 🇨🇳
Dalin He, Xi'an, Shaanxi, China
Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2022-09-08
- Target Recruit Count
- 140
- Registration Number
- NCT05532072
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer
Not yet recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2022-08-31
- Target Recruit Count
- 1000
- Registration Number
- NCT05522907
- Locations
- 🇨🇳
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT
Active, not recruiting
- Conditions
- MalnutritionLiver Cirrhosis
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2024-04-03
- Target Recruit Count
- 2000
- Registration Number
- NCT05513651
- Locations
- 🇨🇳
First Affiliated Hospital Xi'an Jiaotong University, Xi'an, Shannxi, China
Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
- Conditions
- Type 2 Diabetes Mellitus With Complication
- Interventions
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2022-08-24
- Target Recruit Count
- 80
- Registration Number
- NCT05513729
- Locations
- 🇨🇳
First Affiliated Hospital Xi'an Jiaotong University, Xi'an, Shannxi, China
Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2022-09-28
- Target Recruit Count
- 1000
- Registration Number
- NCT05500937
- Locations
- 🇨🇳
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
First-line Replacement Maintenance of Envafolimab in Advanced NSCLC
Phase 2
Not yet recruiting
- Conditions
- Non-Small-Cell Lung
- Interventions
- Drug: Envafolimab;Pemetrexed
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2022-07-20
- Target Recruit Count
- 25
- Registration Number
- NCT05465733
- Locations
- 🇨🇳
The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shanxi, China
The Role of Intraoperative Navigation-assisted Channel Screw Technique in the Treatment of Pelvic Fractures
Not Applicable
Not yet recruiting
- Conditions
- Pelvic Fracture
- Interventions
- Procedure: Open reduction and internal fixation with steel plateProcedure: Intraoperative navigation combined with Catheter screw technique
- First Posted Date
- 2022-07-08
- Last Posted Date
- 2022-08-01
- Target Recruit Count
- 100
- Registration Number
- NCT05448911
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
Phase 2
Not yet recruiting
- Conditions
- Urinary Bladder Neoplasms
- Interventions
- Procedure: Transurethral resection of bladder tumorRadiation: Adjuvant radiotherapy
- First Posted Date
- 2022-07-06
- Last Posted Date
- 2022-12-28
- Target Recruit Count
- 65
- Registration Number
- NCT05445648
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease
Phase 4
Not yet recruiting
- Conditions
- SafetyTreatmentEfficacyAlzheimer Disease
- Interventions
- Drug: GV-971 capsule
- First Posted Date
- 2022-06-24
- Last Posted Date
- 2022-07-07
- Target Recruit Count
- 150
- Registration Number
- NCT05430867
© Copyright 2025. All Rights Reserved by MedPath